Hundreds of thousands of users use the free app to track ovulation, menstrual periods, and other health information
By Physician’s Briefing Staff HealthDay Reporter
THURSDAY, May 18, 2023 (HealthDay News) — Owners of the free fertility app Premom have settled with users after sharing health data without consent to other companies, including Google and marketing firms in China. The U.S. Federal Trade Commission (FTC) announced the $200,000 settlement with Premom owner Easy Healthcare.
“Premom broke its promises and compromised consumers’ privacy,” Samuel Levine, director of the FTC Bureau of Consumer Protection, said in an FTC news release. “We will vigorously enforce the Health Breach Notification Rule to defend consumer’s health data from exploitation. Companies collecting this information should be aware that the FTC will not tolerate health privacy abuses.”
As part of a proposed settlement, the company agreed to a $100,000 civil penalty and another $100,000 to be paid to Connecticut, Oregon, and the District of Columbia for violating their laws.
Hundreds of thousands of users use the free app to track ovulation, menstrual periods, and other health information. The app encourages users to provide information about their cycles, fertility, and pregnancy and to import data from other apps such as Apple Health, the FTC said. It said the company shared data for advertising purposes without disclosing this to users, getting their permission, or limiting how that information could be used.
The U.S. Department of Justice filed a proposed court order Wednesday on behalf of the FTC. As part of that order, Easy Healthcare would be barred from sharing users’ personal health data with third parties for advertising. It would also be required to obtain users’ consent before sharing health data for any other purpose and must tell consumers how their personal data will be used, the FTC said. The proposed order must be approved by the federal court to go into effect.
Easy Healthcare did not admit wrongdoing. “Rather, it is a settlement to avoid the time and expense of litigation and enables us to put this matter behind us and focus on you, our users,” the company wrote in a statement on the Premom website. “Rest assured that we do not, and will not, ever sell any information about users’ health to third parties, nor do we share it for advertising purposes.”
Copyright © 2023 HealthDay. All rights reserved.
